Evidence map›Paper›PMID 16759392›Full record

ArticleBMC genetics2006

Visualization of C. elegans transgenic arrays by GFP.

Aidyl S Gonzalez-Serricchio, Paul W Sternberg

Open access · diamondAbstract read
In one paragraph

Article in BMC genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A cGAL-UAS bipartite expression toolkit forProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Review
  6. Article
  7. A Role forCells · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Analysis of Meiotic Sister Chromatid Cohesion in Caenorhabditis elegans.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. cgChIP: a cell type- and gene-specific method for chromatin analysis.Methods in molecular biology (Clifton, N.J.) · 2014
    Article
  20. Selectable genetic markers for nematode transgenesis.Cellular and molecular life sciences : CMLS · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Aidyl S Gonzalez-SerricchioDepartment of Biological Sciences, California State Polytechnic University, 3801 W Temple Avenue, Pomona, CA 91768, USA. aidyl@csupomona.edu
Paul W Sternberg
California Institute of Technology · USCalifornia State Polytechnic University · US

Funding

GENETIC CONTROL OF NEMATODE VULVAL DEVELOPMENTR01HD023690 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI STERNBERG, PAUL WARREN · 1988 to 1999
–
NICHD NIH HHS HD23690
6 · The paper itself

Abstract

backgroundTargeting the green fluorescent protein (GFP) via the E. coli lac repressor (LacI) to a specific DNA sequence, the lac operator (lacO), allows visualization of chromosomes in yeast and mammalian cells. In principle this method of visualization could be used for genetic mosaic analysis, which requires cell-autonomous markers that can be scored easily and at single cell resolution. The C. elegans lin-3 gene encodes an epidermal growth factor family (EGF) growth factor. lin-3 is expressed in the gonadal anchor cell and acts through LET-23 (transmembrane protein tyrosine kinase and ortholog of EGF receptor) to signal the vulval precursor cells to generate vulval tissue. lin-3 is expressed in the vulval cells later, and recent evidence raises the possibility that lin-3 acts in the vulval cells as a relay signal during vulval induction. It is thus of interest to test the site of action of lin-3 by mosaic analysis.

resultsWe visualized transgenes in living C. elegans by targeting the green fluorescent protein (GFP) via the E. coli lac repressor (LacI) to a specific 256 sequence repeat of the lac operator (lacO) incorporated into transgenes. We engineered animals to express a nuclear-localized GFP-LacI fusion protein. C. elegans cells having a lacO transgene result in nuclear-localized bright spots (i.e., GFP-LacI bound to lacO). Cells with diffuse nuclear fluorescence correspond to unbound nuclear localized GFP-LacI. We detected chromosomes in living animals by chromosomally integrating the array of the lacO repeat sequence and visualizing the integrated transgene with GFP-LacI. This detection system can be applied to determine polyploidy as well as investigating chromosome segregation. To assess the GFP-LacI*lacO system as a marker for mosaic analysis, we conducted genetic mosaic analysis of the epidermal growth factor lin-3, expressed in the anchor cell. We establish that lin-3 acts in the anchor cell to induce vulva development, demonstrating this method's utility in detecting the presence of a transgene.

conclusionThe GFP-LacI*lacO transgene detection system works in C. elegans for visualization of chromosomes and extrachromosomal transgenes. It can be used as a marker for genetic mosaic analysis. The lacO repeat sequence as an extrachromosomal array becomes a valuable technique allowing rapid, accurate determination of spontaneous loss of the array, thereby allowing high-resolution mosaic analysis. The lin-3 gene is required in the anchor cell to induce the epidermal vulval precursors cells to undergo vulval development.

Indexed as

MosaicismPolyploidyTransgenesAnimalsAnimals, Genetically ModifiedBacterial ProteinsCaenorhabditis elegansCaenorhabditis elegans ProteinsChromosomesEpidermal Growth FactorFemaleGreen Fluorescent ProteinsLac RepressorsLuminescent AgentsRecombinant Fusion ProteinsRepressor ProteinsBacterial ProteinsCaenorhabditis elegans ProteinsEpidermal Growth FactorGreen Fluorescent ProteinsLac RepressorsLin-3 protein, C elegansLuminescent AgentsRecombinant Fusion ProteinsRepressor Proteins

Identifiers

PMID16759392
PMCPMC1539001
OpenAlexW1549453958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.